In addition, Dementyeva et al. (2013) found that in case of multiple myeloma, patients with positive centrosome amplification showed lower TUBG1 expression levels, reporting better prognosis for centrosome amplification-positive newly diagnosed patients. This evidence concerns the gene TUBG1 and plasma cell myeloma.